State of Wisconsin Investment Board

FluGen, Inc. is a biopharmaceutical company based in Madison, Wisconsin, focused on developing vaccines to prevent diseases caused by influenza viruses. Founded in 2007, FluGen specializes in both seasonal and pandemic influenza prevention. The company offers RedeeFlu, a nasal spray vaccine, and utilizes a vaccine-loaded intradermal microneedle delivery device. FluGen's innovative approach includes the use of a live, single replication, intranasally delivered virus with a deleted M2 segment (M2SR), enhancing its ability to prevent the spread of influenza and other respiratory pathogens, including COVID-19.

FluGen, Inc. is a biopharmaceutical company based in Madison, Wisconsin, focused on developing vaccines to prevent diseases caused by influenza viruses. Founded in 2007, FluGen specializes in both seasonal and pandemic influenza prevention. The company offers RedeeFlu, a nasal spray vaccine, and utilizes a vaccine-loaded intradermal microneedle delivery device. FluGen's innovative approach includes the use of a live, single replication, intranasally delivered virus with a deleted M2 segment (M2SR), enhancing its ability to prevent the spread of influenza and other respiratory pathogens, including COVID-19.

EatStreet is a food delivery and online ordering platform that connects diners with local restaurants across the United States. The service operates via web and mobile apps, including iPhone and Android, enabling users to order delivery or takeout from their favorite eateries. Founded in 2009 and headquartered in Madison, Wisconsin, EatStreet provides a centralized hub for restaurants to reach new customers and manage online ordering and marketing. The platform aggregates partner restaurants into a comprehensive listing and offers a streamlined ordering experience, helping diners discover options and restaurants grow their sales.

FluGen, Inc. is a biopharmaceutical company based in Madison, Wisconsin, focused on developing vaccines to prevent diseases caused by influenza viruses. Founded in 2007, FluGen specializes in both seasonal and pandemic influenza prevention. The company offers RedeeFlu, a nasal spray vaccine, and utilizes a vaccine-loaded intradermal microneedle delivery device. FluGen's innovative approach includes the use of a live, single replication, intranasally delivered virus with a deleted M2 segment (M2SR), enhancing its ability to prevent the spread of influenza and other respiratory pathogens, including COVID-19.

Founded in 2004 and based in Madison, Wisconsin, NeuWave Medical develops high-quality, minimally invasive medical devices that use energy to treat various serious health conditions. Led by founders who are both engineers and physician-scientists, the company aims to create clinically relevant and effective solutions, making its products the preferred choice for leading healthcare providers worldwide.

Rentable is an internet company founded in 2011 and based in Madison, Wisconsin, that focuses on enhancing the apartment rental search experience. The company offers a web-based platform that features localized flat listings, search aids, and map-based searches. Its intuitive user design and robust search functionality allow users to browse apartment listings easily and calculate rent affordability. By leveraging modern technology, Rentable aims to streamline the process of finding suitable rental properties, catering to the needs of rent seekers looking for a more efficient way to search for apartments.

Zurex Pharma, Inc. is a pharmaceutical and medical technology company focused on developing and commercializing innovative antimicrobial products aimed at preventing healthcare-associated infections, particularly in surgical site wounds and catheter-related scenarios. The company’s product offerings include ZuraPrep, a pre-surgical skin preparation designed to minimize the risk of surgical site infections; ZurAsept, an antimicrobial and antithrombotic catheter solution that addresses catheter-related bloodstream infections; and ZuraGard, which protects against extra-luminal or exit site infections. Founded in 2008 and headquartered in Middleton, Wisconsin, Zurex Pharma operates as a subsidiary of Ash Access Technology, Inc. The company is dedicated to overcoming scientific and technical challenges in infection prevention, providing healthcare professionals with effective solutions to enhance patient safety.

Neurovance, Inc. is a clinical-stage neuroscience company headquartered in Cambridge, Massachusetts, focused on developing and commercializing therapies for attention deficit hyperactivity disorder (ADHD) in both adults and children. Founded in 2009, Neurovance has developed centanafadine, a triple reuptake inhibitor that precisely modulates the activity of norepinephrine, dopamine, and serotonin to enhance focus and address symptoms of inattention and disorganization in ADHD patients. As of 2017, Neurovance operates as a subsidiary of Otsuka America, Inc.

EatStreet is a food delivery and online ordering platform that connects diners with local restaurants across the United States. The service operates via web and mobile apps, including iPhone and Android, enabling users to order delivery or takeout from their favorite eateries. Founded in 2009 and headquartered in Madison, Wisconsin, EatStreet provides a centralized hub for restaurants to reach new customers and manage online ordering and marketing. The platform aggregates partner restaurants into a comprehensive listing and offers a streamlined ordering experience, helping diners discover options and restaurants grow their sales.

Montage Talent, Inc. specializes in providing live and on-demand voice and video interviewing solutions tailored for large enterprises, healthcare sectors, and staffing and recruitment process outsourcing firms. Established in 2007 and based in Delafield, Wisconsin, the company was previously known as Expressume, Inc. and adopted its current name in 2001. Montage serves a diverse clientele, including numerous Fortune 500 companies, by delivering a modern hiring experience that combines advanced technology with personalized service. As a pioneer in purpose-built video interviewing, Montage's proprietary platform is designed for reliability, scalability, compliance, and security, ensuring it meets enterprise demands. The company emphasizes innovation driven by market needs and data, aiming to enhance the efficiency and predictability of talent acquisition. Additionally, Montage is dedicated to fostering long-term client relationships and providing exceptional support at every stage of the hiring process.

Neurovance, Inc. is a clinical-stage neuroscience company headquartered in Cambridge, Massachusetts, focused on developing and commercializing therapies for attention deficit hyperactivity disorder (ADHD) in both adults and children. Founded in 2009, Neurovance has developed centanafadine, a triple reuptake inhibitor that precisely modulates the activity of norepinephrine, dopamine, and serotonin to enhance focus and address symptoms of inattention and disorganization in ADHD patients. As of 2017, Neurovance operates as a subsidiary of Otsuka America, Inc.

Founded in 2004 and based in Madison, Wisconsin, NeuWave Medical develops high-quality, minimally invasive medical devices that use energy to treat various serious health conditions. Led by founders who are both engineers and physician-scientists, the company aims to create clinically relevant and effective solutions, making its products the preferred choice for leading healthcare providers worldwide.

Roche NimbleGen is a biotechnology company headquartered in Madison, Wisconsin, that specializes in providing products and services for the life science research market. The company offers a range of solutions including the SeqCap EZ system, which enhances exome enrichment in a single test tube, as well as various library construction kits and reagents. Roche NimbleGen's SeqCap Epi system focuses on DNA methylation assessment, providing tools for single-base resolution analysis. The company utilizes its proprietary Maskless Array Synthesis technology to manufacture high-density DNA microarrays, improving the quality and yield of DNA sequencing data. Additionally, Roche NimbleGen offers software tools such as SignalMap for genomic data visualization and NimbleDesign for library design, alongside comprehensive online technical support. Established in 1999, Roche NimbleGen operates as a subsidiary of Roche Holding AG, emphasizing research and innovation in genomic technologies.

Roche NimbleGen is a biotechnology company headquartered in Madison, Wisconsin, that specializes in providing products and services for the life science research market. The company offers a range of solutions including the SeqCap EZ system, which enhances exome enrichment in a single test tube, as well as various library construction kits and reagents. Roche NimbleGen's SeqCap Epi system focuses on DNA methylation assessment, providing tools for single-base resolution analysis. The company utilizes its proprietary Maskless Array Synthesis technology to manufacture high-density DNA microarrays, improving the quality and yield of DNA sequencing data. Additionally, Roche NimbleGen offers software tools such as SignalMap for genomic data visualization and NimbleDesign for library design, alongside comprehensive online technical support. Established in 1999, Roche NimbleGen operates as a subsidiary of Roche Holding AG, emphasizing research and innovation in genomic technologies.